An ESIPT based fluorescent probe for imaging hydrogen sulfide with a large turn-on fluorescence signal

Beibei Deng, Mingguang Ren, Xiuqi Kong, Kai Zhou and Weiying Lin*
Institute of Fluorescent Probes for Biological Imaging, School of Chemistry and Chemical Engineering, School of Biological Science and Technology, University of Jinan, Jinan, Shandong 250022, P. R. China. E-mail: weiyinglin2013@163.com

Received 10th May 2016 , Accepted 21st June 2016

First published on 22nd June 2016


Abstract

Through an intramolecular nucleophilic substitution reaction and ESIPT mechanism, we designed and synthesized a fluorescent hydrogen sulfide probe with a large turn on fluorescence signal (400-fold). The new probe exhibits high selectivity, good membrane-permeability and is suitable for the visualization of exogenous and endogenous hydrogen sulfide in living cells.


Hydrogen sulfide (H2S), well known for its pungent smell and noxious nature, is an important endogenous gasotransmitter, which is associated with diverse physiological processes.1 It is clear that hydrogen sulfide now sits with nitric oxide and carbon monoxide as one of three gaseous mediators in biology. H2S is endogenously produced by enzymes such as cystathionine γ-lyase (CSE), cystathionine β-synthase (CBS), cysteine aminotransferase (CAT) and 3-mercaptopyruvate sulphurtransferase (MST).2 H2S has both beneficial and detrimental sides for organisms. On the one hand, accumulating evidence has confirmed that hydrogen sulfide is involved in a vast number of physiological and pathological processes, such as ischemia reperfusion injury, vasodilation, apoptosis, insulin signaling, and oxygen sensing.3 On the other hand, overexposure to the corrosive and flammable gas can cause eye irritation, and inflammation in the respiratory tract.4 In the human body, abnormal H2S levels have also been associated with various diseases including Alzheimer's disease,5 Down's syndrome,6 diabetes,7 and liver cirrhosis.8 Therefore, it is very necessary to develop an efficient method for sensitively and selectively probing H2S in living systems.

Several analytical techniques including colorimetric,9 electrochemical assay,10 polarographic analysis,11 and sulfide precipitation12 have been devoted in detection of H2S. Compared with those detection methods, fluorescence imaging has been widely used as a powerful tool for monitoring biomolecules within the context of living systems with high spatial and temporal resolution.13 Recently, some groups have made great progresses in the detection of H2S in blood and in cells.14 Among them, various photomechanisms were used in the design of fluorescent H2S probe, including internal charge transfer (ICT),14e–h Förster resonance energy transfer (FRET),14i–l and rhodamine close–open ring process.14m,n Excited state intramolecular proton transfer (ESIPT) is also a significantly important fluorescent phenomenon, which generally involves a hydroxyl proton transfer to an acceptor in the excited state. In comparison with the other fluorescent processes, such as electron transfer and energy transfer, ESIPT process can occur at a much faster rate.15 Fluorescence sensing based on ESIPT is quite promising by virtue of low background signal in aqueous media, good photo-stability, intramolecular hydrogen-bonded property, and spectral sensitivity to the surrounding medium. Moreover, ESIPT dyes generally have large Stokes shift, which can reduce the interference from the excitation light.16

Among ESIPT dyes, the molecule 2-(2′-hydroxyphenyl)-benzothiazole (HBT) and its derivatives are a potentially interesting moiety as an fluorophore being widely used.17 In addition, azido group is well-known for sensitively and selectively responding to H2S, based on the specific reduction of azide by H2S to generate the corresponding amine.18

Herein, in this work, we employed the HBT chromophore as the signal reporter and azido group as the responding site for H2S to construct a fluorescent H2S probe (ESIPT-HS) based on ESIPT process. Compared with the previous reports,17b,19 the probe ESIPT-HS possesses a large turn-on fluorescence signal enhancement (an approximately 400-fold) and could be used to imaging endogenous H2S in living cells (as shown in Table S1). This is mainly attributed to the probe with relatively low background fluorescence and high sensitivity to H2S. We investigated its optical properties, response rate and selectivity toward various reactive sulphur, ROSs and reactive nitrogen species. The result suggests that it possesses high selectivity. Besides, the cell imaging confirmed that the probe ESIPT-HS can be used to monitor the level of H2S in living cells.

Compound HBT and compound 1 were prepared according to a literature procedure.20 The target compound ESIPT-HS was readily synthesized in one simple step. Treatment of compound 1 with DCC and DMAP in DCM and added HBT in room temperature afforded sensor ESIPT-HS in good yield (Scheme 1). The structure of the target compound synthesized was fully characterized by standard 1H-NMR, 13C-NMR and mass spectrometry (see ESI).


image file: c6ra12127f-s1.tif
Scheme 1 Synthesis and response mechanism of the fluorescent probe ESIPT-HS.

With the probe ESIPT-HS in hand, we firstly evaluated the capability of ESIPT-HS to detect H2S in aqueous buffer. The titration of Na2S was carried out and employed to replace H2S in this work. H2S is a weak acid in aqueous solutions (pKa1 = 7.04, pKa2 = 11.96), equilibrating mainly with HS at physiological pH. For example, at pH 7.4 and temperature of 37 °C, 18.5% of free hydrogen sulfide exists as H2S molecule and the remainder is almost all hydrosulfide anion (HS) with a negligible contribution of S2.21 So, as the ion distribution of Na2S is the same with that of H2S in a neutral buffer solution. As shown in Fig. 1, ESIPT-HS has nearly no absorption in the visible region. However, with the addition of Na2S to the solution, the absorption at 381 nm was gradually increased, as well as the absorption peak at 300 nm was also increased slightly. In good agreement with the absorption spectra, upon excitation at 410 nm, the free probe ESIPT-HS displays a weak fluorescent emission, owing to the inhabited of ESIPT process, and the fluorescence quantum yield of compound ESIPT-HS is only 0.00281. By contrast, addition of Na2S renders the fluorescence intensity a drastic large (up to 400-fold) fluorescence increase in the emission of 462 nm was observed, owing to the cleavage reaction of ESIPT-HS would trigger by H2S and release the fluorescent of HBT with a stronger ESITP emission. In this case the fluorescence quantum efficiency is as high as 0.265, after the probe response with Na2S. Consistently, the visual emission color of the probe ESIPT-HS solution turned from no color to pale yellow and the fluorescent emission under a UV lamp with excitation of 365 nm could be observed by naked eyes and turned from no color to blue color (Fig. S1). A linear calibration curve was obtained between the fluorescence signal at 462 nm and the concentration of Na2S up to 60 μM, (Fig. S2), which indicated that the chemodosimeter is suitable for quantitative determination of H2S. In addition, the probe showed relatively high sensitivity to H2S with a detection limit of 2.21 × 10−6 M under the experimental conditions, which is much lower than the physiological H2S concentration in mammalian serum (30–100 μM) and in the brain (160 μM),22 (Fig. S3), indicating that the probe ESIPT-HS has enough sensitive to determine the H2S in physiological condition.


image file: c6ra12127f-f1.tif
Fig. 1 The absorption (a) and fluorescence (b) spectral changes of probe ESIPT-HS (10 μM) upon addition of increasing concentrations of Na2S (0–20 equiv.) (Ex = 410 nm) in 20 mM PBS buffer, pH 7.4, containing 30% DMSO as a cosolvent.

To shed light on the H2S-triggered fluorescence turn-on response, we decided to characterize the reduced product. Incubation of ESIPT-HS with Na2S afforded the product, which was isolated and characterized by standard 1H-NMR (Fig. 2). Compared with the 1H-NMR of HBT, we found that the 1H-NMR spectra of the isolated compound is the same as that of HBT. From the above experimental results, we can deduce the recognition mechanism of the probe to H2S. ESIPT-HS can react with H2S to form the intermediate ESIPT-NH. However, ESIPT-NH is a NH2 containing compound, which can spontaneously cyclize with ester groups to release the fluorophore HBT and the other by-product BP-N.


image file: c6ra12127f-f2.tif
Fig. 2 (a) 1H NMR spectrum of the compound HBT. (b) 1H NMR spectrum of the isolated product of the probe ESIPT-HS reacted with Na2S.

We then decided to examine the effect of pH on the fluorescence properties of ESIPT-HS and its response to H2S. As shown in Fig. 3, the emission intensities of ESIPT-HS are quite low and do not change significantly over a wide ranges of pH from 1.5–10.5, indicating that the free probe was stable in the wide pH range. Upon addition of Na2S, ESIPT-HS emits weak fluorescent emission in the acid environment range of pH from 1.5 to 6.4. However, with the increase of pH from 6.4 to 10.5, an enhancement trend is observed in ESIPT-HS fluorescence intensity of response to H2S. We speculate that such results are mainly due to the pH effect on the fluorescence spectra of the reaction product HBT. As shown in Fig. S4, the trend of fluorescence intensity of HBT at 462 nm with the change of pH value was consistent with the response of the probe to H2S at in different pH test solution. ESIPT-HS displays a relatively strong fluorescence response at the pH range of 7.4–8.5, implying that the probe can be suitable to detect H2S at a physiological pH conditions.


image file: c6ra12127f-f3.tif
Fig. 3 Fluorescence intensity changes of the probe ESIPT-HS (10 μM) at different pH values in the absence (image file: c6ra12127f-u1.tif) or presence (image file: c6ra12127f-u2.tif) of Na2S (50 μM) in PBS buffer (containing 30% DMSO as a cosolvent).

The time course of the fluorescence intensities of ESIPT-HS (10 μM) in the presence of H2S in PBS buffer pH 7.4 is displayed in Fig. S5. Notably, a drastic increase in fluorescence intensity was observed in 40 min, and a plateau was reached within 70 minutes in the presence of H2S (50 μM). In spite of the speed of the probe response to H2S is not very fast, but within few minutes the fluorescence enhancement ratio is enough to apply to cell imaging. Therefore, the results of timescale may allow ESIPT-HS to sense H2S in real-time intracellular imaging.

Generally, realizing higher selectivity toward a specific analyte over other potential competing species is necessary for a fluorescence chemosensor. To examine the selectivity, the probe ESIPT-HS was treated with various biologically relevant analytes to establish a selectivity profile, such as anions, reactive oxygen species, small molecule thiols and Na2S in PBS buffer pH 7.4 (containing 30% DMSO as a cosolvent). As exhibited in Fig. 4 and S6, the representative species Br; F; H2PO4; HPO42−; S2O32−; SO32−; HSO3; ClO; H2O2 were all prepared at 50 μM. Remarkably, all these representative interfering species induced no marked fluorescence response. However, upon addition of Na2S a large fluorescence spectrum was observed, around 462 nm. Biological thiols (Cys, GSH, Hcy) exerted a negligible change on the fluorescence response for ESIPT-HS. These results suggest that the probe ESIPT-HS is highly selective for H2S over other tested species. In this regard, ESIPT-HS can be considered as a good off–on chemosensor for specific recognition of H2S.


image file: c6ra12127f-f4.tif
Fig. 4 Fluorescence intensities of ESIPT-HS (10 μM) treated with various species (50 μM) in PBS buffer (pH 7.4, containing 30% DMSO as a cosolvent).

Encouraged by the above mentioned desirable properties of the spectroscopic data establishing that the probe can selectively respond to H2S in aqueous solution with a large turn on fluorescence signal, we evaluated ESIPT-HS imaging assays of H2S in live cells, and fluorescence imaging experiments were carried out in living cells (HeLa cells) on confocal laser scanning microscopy. The cytotoxicity of ESIPT-HS was examined toward HeLa cells by a MTT assay (Fig. S7). The result indicates that the probe ESIPT-HS at the low micromolar concentrations has no marked cytotoxicity to the cells after a long period (>90% HeLa cells survived after 24 h with 30.0 μM ESIPT-HS incubation). Thus, the favorable properties of the probe include low cytotoxicity, which may render the probe ESIPT-HS suitable for imaging H2S in living cells.

The utility of probe ESIPT-HS for fluorescence imaging of exogenous H2S in living cells was investigated. As shown in Fig. 5, ESIPT-HS (5 μM) was initially incubated with HeLa cells for 20 min, and then rinsed three times by PBS buffer to remove excess of ESIPT-HS. The HeLa cells incubated with only the probe ESIPT-HS exhibited very weak fluorescence signal seen from the confocal imaging (Fig. 5b; λex = 405 nm; λem = 425–475 nm). In contract, when incubated with 5.0 μM probe ESIPT-HS for 20 min and then treated with 50 μM Na2S for another 30 min, HeLa cells displayed enhanced fluorescence in the blue channel at the same test conditions (Fig. 5e). These data established that the probe ESIPT-HS with suitable amphipathicity is cell membrane permeable and able to display a fluorescence turn-on response to H2S in the living cells.


image file: c6ra12127f-f5.tif
Fig. 5 Imaging of exogenous H2S in HeLa cells stained with the probe ESIPT-HS (a) brightfield image of HeLa cells costained only with ESIPT-HS; (b) fluorescence images of (a) from blue channel; (c) overlay of (a) and (b); (d) brightfield image of HeLa cells costained with ESIPT-HS and treated with Na2S; (e) fluorescence images of (d) from blue channel; (f) overlay of the brightfield image (d) and blue channel (e).

To obtain insight into the efficacy of the probe in the detection of endogenous H2S, we determine to detect intrinsically biosynthesized H2S inside the cells. Cysteine could be catalyzed by cystathionine β-synthase (CBS) and cystathionine γ-lyase (CSE) in living cells for H2S production.23 HeLa cells were treated with 10.0 μM ESIPT-HS and then stimulated with 200 μM cysteine for 2 hour. As shown in Fig. 6, the cells without stimulated with cysteine and loaded with only the probe ESIPT-HS (10.0 μM) displayed a weak fluorescence in the blue channel (Fig. 6b). However, the cells stimulated with cysteine and then treated with probe ESIPT-HS exhibit a dramatic enhancement in the blue channel (Fig. 6e). These results demonstrate that ESIPT-HS is capable of detecting not only exogenous H2S in living cells, but also H2S biologically produced by the cells.


image file: c6ra12127f-f6.tif
Fig. 6 Imaging of endogenous H2S in living cells. (a) Brightfield image of HeLa cells costained with ESIPT-HS; (b) fluorescence images of (a) from blue channel; (c) overlay of (a) and (b); (d) brightfield image of HeLa cells stimulated with cysteine (100 μM mL−1) and costained with ESIPT-HS, (e) fluorescence images of (d) from blue channel; (f) overlay of the brightfield image (d) and blue channel (e).

In summary, the probe ESIPT-HS was developed fluorescent H2S probe based on ESIPT process with a large turn-on fluorescence signal. The addition of H2S to ESIPT-HS results in a large fluorescence enhancement at 462 nm because of the fluorescent of the probe triggered by H2S and released the blue fluorescent of HBT with a stronger ESIPT-state emission. The probe exhibited favorable properties such as large turn on fluorescence signal, large Stokes shift, good selectivity and low cytotoxicity. Fluorescence imaging shows that ESIPT-HS was membrane-permeable and suitable for visualization of exogenous and endogenous H2S in living cells.

Acknowledgements

This work was financially supported by NSFC (21172063, 21472067, 21502067), the Natural Science Foundation of Shandong Province, China (ZR2014BP001), Taishan Scholar Foundation (TS 201511041), and the startup fund of University of Jinan (160082101).

Notes and references

  1. (a) C. Szabo, Nat. Rev. Drug Discovery, 2007, 6, 917 CrossRef CAS PubMed; (b) L. Li, P. Rose and P. K. Moore, Annu. Rev. Pharmacol., 2011, 51, 169 CrossRef CAS PubMed.
  2. (a) S. Singh, D. Padovani, R. A. Leslie, T. Chiku and R. Banerjee, J. Biol. Chem., 2009, 284, 22457 CrossRef CAS PubMed; (b) J. E. Dominy and M. H. Stipanuk, Nutr. Rev., 2004, 62, 348 Search PubMed; (c) O. Kabil and R. Banerjee, J. Biol. Chem., 2010, 285, 21903 CrossRef CAS PubMed; (d) N. Shibuya, M. Tanaka, M. Yoshida, Y. Ogasawara, T. Togawa, K. Ishii and H. Kimura, Antioxid. Redox Signaling, 2008, 11, 703 CrossRef PubMed.
  3. (a) L. Li, M. Bhatia, Y. Z. Zhu, Y. C. Zhu, R. D. Ramnath, Z. J. Wang, F. B. Anuar, M. Whiteman, M. Salto-Tellez and P. K. Moore, FASEB J., 2005, 19, 1196 CrossRef CAS PubMed; (b) G. Yang, L. Wu and R. Wang, FASEB J., 2006, 20, 553 CrossRef CAS PubMed; (c) K. Abe and H. Kimura, J. Neurosci., 1996, 16, 1066 CAS; (d) G. Yang, L. Wu, B. Jiang, W. Yang, J. Qi, K. Cao, Q. Meng, A. K. Mustafa, W. Mu, S. Zhang, S. H. Snyder and R. Wang, Science, 2008, 322, 587 CrossRef CAS PubMed.
  4. C. L. Evans, Exp. Physiol., 1967, 52, 231 CrossRef CAS.
  5. K. Eto, T. Asada, K. Arima, T. Makifuchi and H. Kimura, Biochem. Biophys. Res. Commun., 2002, 293, 1485 CrossRef CAS PubMed.
  6. P. Kamoun, M.-C. Belardinelli, A. Chabli, K. Lallouchi and B. Chadefaux-Vekemans, Am. J. Med. Genet., Part A, 2003, 116, 310 CrossRef PubMed.
  7. W. Yang, G. Yang, X. Jia, L. Wu and R. Wang, J. Physiol., 2005, 569, 519 CrossRef CAS PubMed.
  8. S. Fiorucci, E. Antonelli, A. Mencarelli, S. Orlandi, B. Renga, G. Rizzo, E. Distrutti, V. Shah and A. Morelli, Hepatology, 2005, 42, 539 CrossRef CAS PubMed.
  9. J. Bae, M. G. Choi, J. Choi and S.-K. Chang, Dyes Pigm., 2013, 99, 748 CrossRef CAS.
  10. N. S. Lawrence, J. Davis, L. Jiang, T. G. J. Jones, S. N. Davies and R. G. Compton, Electroanalysis, 2000, 12, 1453 CrossRef CAS.
  11. J. E. Doeller, T. S. Isbell, G. Benavides, J. Koenitzer, H. Patel, R. P. Patel, J. R. Lancaster Jr, V. M. Darley-Usmar and D. W. Kraus, Anal. Biochem., 2005, 341, 40 CrossRef CAS PubMed.
  12. M. Ishigami, K. Hiraki, K. Umemura, Y. Ogasawara, K. Ishii and H. Kimura, Antioxid. Redox Signaling, 2008, 11, 205 CrossRef PubMed.
  13. H. Kobayashi, M. Ogawa, R. Alford, P. L. Choyke and Y. Urano, Chem. Rev., 2009, 110, 2620 CrossRef PubMed.
  14. (a) F. B. Yu, X. Y. Han and L. X. Chen, Chem. Commun., 2014, 50, 12234 RSC; (b) A. R. Lippert, J. Inorg. Biochem., 2014, 133, 136 CrossRef CAS PubMed; (c) V. S. Lin, W. Chen, M. Xian and C. J. Chang, Chem. Soc. Rev., 2015, 44, 4596 RSC; (d) L. He, W. Lin, Q. Xu and H. Wei, Chem. Commun., 2015, 51, 1510 RSC; (e) M.-Y. Wu, K. Li, J.-T. Hou, Z. Huang and X.-Q. Yu, Org. Biomol. Chem., 2012, 10, 8342 RSC; (f) Q. Wan, Y. Song, Z. Li, X. Gao and H. Ma, Chem. Commun., 2013, 49, 502 RSC; (g) X. Li, S. Zhang, J. Cao, N. Xie, T. Liu, B. Yang, Q. He and Y. Hu, Chem. Commun., 2013, 49, 8656 RSC; (h) X. L. Liu, X. J. Du, C. G. Dai and Q.-H. Song, J. Org. Chem., 2014, 79, 9481 CrossRef CAS PubMed; (i) Z. Guo, G. Chen, G. Zeng, Z. Li, A. Chen, J. Wang and L. Jiang, Analyst, 2015, 140, 1772 RSC; (j) L. He, W. Lin, Q. Xu and H. Wei, Chem. Commun., 2015, 51, 1510 RSC; (k) K. Huang, L. Yu, P. Xu, X. Zhang and W. Zeng, RSC Adv., 2015, 5, 17797 RSC; (l) X. Feng, T. Zhang, J. T. Liu, J. Y. Miao and B. X. Zhao, Chem. Commun., 2016, 52, 3131 RSC; (m) X. Chen, S. Wu, J. Han and S. Han, Bioorg. Med. Chem. Lett., 2013, 23, 5295 CrossRef CAS PubMed; (n) C. Liu, H. Wu, B. Han, B. Zhu and X. Zhang, Dyes Pigm., 2014, 110, 214 CrossRef CAS.
  15. M. Y. Berezin and S. Achilefu, Chem. Rev., 2010, 110, 2641 CrossRef CAS PubMed.
  16. K. Hanaoka, K. Kikuchi, H. Kojima, Y. Urano and T. Nagano, J. Am. Chem. Soc., 2004, 126, 12470 CrossRef CAS PubMed.
  17. (a) Z. Xu, L. Xu, J. Zhou, Y. Xu, W. Zhu and X. Qian, Chem. Commun., 2012, 48, 10871 RSC; (b) Y. Jiang, Q. Wu and X. Chang, Talanta, 2014, 121, 122 CrossRef CAS PubMed; (c) C. Y. Liu, Z. M. Cao, Z. H. Wang, P. Jia, J. Liu, Z. K. Wang, B. J. Han, X. Huang, X. Li, B. C. Zhu and X. L. Zhang, Sens. Actuators, B, 2015, 220, 727–733 CrossRef CAS; (d) H.-M. Lv, C. Yi, J. Lei, C.-T. Au and S.-F. Yin, Anal. Methods, 2015, 7, 3883–3887 RSC; (e) P. Xu, T. Gao, M. Liu, H. Zhang and W. Zeng, Analyst, 2015, 140, 1814 RSC.
  18. (a) Q. Qiao, M. Zhao, H. Lang, D. Mao, J. Cui and Z. Xu, RSC Adv., 2014, 4, 25790 RSC; (b) T. Ozdemir, F. Sozmen, S. Mamur, T. Tekinay and E. U. Akkaya, Chem. Commun., 2014, 50, 5455 RSC; (c) W. Sun, J. Fan, C. Hu, J. Cao, H. Zhang, X. Xiong, J. Wang, S. Cui, S. Sun and X. Peng, Chem. Commun., 2013, 49, 3890 RSC; (d) Q. Wan, Y. Song, Z. Li, X. Gao and H. Ma, Chem. Commun., 2013, 49, 502 RSC; (e) X. L. Liu, X. J. Du, C. G. Dai and Q.-H. Song, J. Org. Chem., 2014, 79, 9481–9489 CrossRef CAS PubMed.
  19. Z. Wu, Z. Li, L. Yang, J. Han and S. Han, Chem. Commun., 2012, 48, 10120 RSC.
  20. (a) A. K. Mahapatra, K. Maiti, S. K. Manna, R. Maji, S. Mondal, C. Das Mukhopadhyay, P. Sahoo and D. Mandal, Chem. Commun., 2015, 51, 9729 RSC; (b) T. Wada, A. Ohkubo, A. Mochizuki and M. Sekine, Tetrahedron Lett., 2001, 42, 1069 CrossRef CAS.
  21. M. N. Hughes, M. N. Centelles and K. P. Moore, Free Radical Biol. Med., 2009, 47, 1346 CrossRef CAS PubMed.
  22. J. L. Wallace, Trends Pharmacol. Sci., 2007, 28, 501 CrossRef CAS PubMed.
  23. Y. Qian, J. Karpus, O. Kabil, S.-Y. Zhang, H.-L. Zhu, R. Banerjee, J. Zhao and C. He, Nat. Commun., 2011, 2, 495 CrossRef PubMed.

Footnote

Electronic supplementary information (ESI) available: Characterization data, and additional spectra. See DOI: 10.1039/c6ra12127f

This journal is © The Royal Society of Chemistry 2016
Click here to see how this site uses Cookies. View our privacy policy here.